Historique
Article de Périodique
Opiate substitution treatment and HIV transmission in people who inject drugs: systematic review and meta-analysis (2012)
Auteur(s) :
MACARTHUR, G. J. ;
MINOZZI, S. ;
MARTIN, N. ;
VICKERMAN, P. ;
DEREN, S. ;
BRUNEAU, J. ;
DEGENHARDT, L. ;
HICKMAN, M.
Année
2012
Page(s) :
e5945
Sous-type de document :
Méta-analyse / Meta-analysis ; Revue de la littérature / Literature review
Langue(s) :
Anglais
Refs biblio. :
72
Domaine :
Drogues illicites / Illicit drugs
Thésaurus mots-clés
TRAITEMENT DE MAINTENANCE
;
SUBSTITUTION
;
VIH
;
USAGER
;
INFECTION
;
INJECTION
;
REDUCTION DES RISQUES ET DES DOMMAGES
;
METHADONE
;
EFFICACITE
Note de contenu :
Editorial: The role of opioid substitution treatment in reducing HIV transmission. Gowing L.R., e6425.
Brève bibliographique dans le Flyer 2013, n°50, p. 17.
Brève bibliographique dans le Flyer 2013, n°50, p. 17.
Résumé :
Objective: To quantify the effect of opiate substitution treatment in relation to HIV transmission among people who inject drugs.
Design: Systematic review and meta-analysis of prospective published and unpublished observational studies.
Data sources: Search of Medline, Embase, PsychINFO, and the Cochrane Library from the earliest year to 2011 without language restriction.
Review methods: We selected studies that directly assessed the impact of opiate substitution treatment in relation to incidence of HIV and studies that assessed incidence of HIV in people who inject drugs and that might have collected data regarding exposure to opiate substitution treatment but not have reported it. Authors of these studies were contacted. Data were extracted by two reviewers and pooled in a meta-analysis with a random effects model.
Results: Twelve published studies that examined the impact of opiate substitution treatment on HIV transmission met criteria for inclusion, and unpublished data were obtained from three additional studies. All included studies examined methadone maintenance treatment. Data from nine of these studies could be pooled, including 819 incident HIV infections over 23 608 person years of follow-up. Opiate substitution treatment was associated with a 54% reduction in risk of HIV infection among people who inject drugs (rate ratio 0.46, 95% confidence interval 0.32 to 0.67; P<0.001). There was evidence of heterogeneity between studies (I²=60%, χ²=20.12, P=0.010), which could not be explained by geographical region, site of recruitment, or the provision of incentives. There was weak evidence for greater benefit associated with longer duration of exposure to opiate substitution treatment.
Conclusion: Opiate substitution treatment provided as maintenance therapy is associated with a reduction in the risk of HIV infection among people who inject drugs. These findings, however, could reflect comparatively high levels of motivation to change behaviour and reduce injecting risk behaviour among people who inject drugs who are receiving opiate substitution treatment.
Design: Systematic review and meta-analysis of prospective published and unpublished observational studies.
Data sources: Search of Medline, Embase, PsychINFO, and the Cochrane Library from the earliest year to 2011 without language restriction.
Review methods: We selected studies that directly assessed the impact of opiate substitution treatment in relation to incidence of HIV and studies that assessed incidence of HIV in people who inject drugs and that might have collected data regarding exposure to opiate substitution treatment but not have reported it. Authors of these studies were contacted. Data were extracted by two reviewers and pooled in a meta-analysis with a random effects model.
Results: Twelve published studies that examined the impact of opiate substitution treatment on HIV transmission met criteria for inclusion, and unpublished data were obtained from three additional studies. All included studies examined methadone maintenance treatment. Data from nine of these studies could be pooled, including 819 incident HIV infections over 23 608 person years of follow-up. Opiate substitution treatment was associated with a 54% reduction in risk of HIV infection among people who inject drugs (rate ratio 0.46, 95% confidence interval 0.32 to 0.67; P<0.001). There was evidence of heterogeneity between studies (I²=60%, χ²=20.12, P=0.010), which could not be explained by geographical region, site of recruitment, or the provision of incentives. There was weak evidence for greater benefit associated with longer duration of exposure to opiate substitution treatment.
Conclusion: Opiate substitution treatment provided as maintenance therapy is associated with a reduction in the risk of HIV infection among people who inject drugs. These findings, however, could reflect comparatively high levels of motivation to change behaviour and reduce injecting risk behaviour among people who inject drugs who are receiving opiate substitution treatment.
Affiliation :
School of Social and Community Medicine, University of Bristol, Bristol BS8 2PS, UK